Effects of selenium on oxidative stress and glycemic control of type 2 diabetes

Phase 4

• Conditions: Type 2 diabetes mellitus.; Diabetes Mellitus; E10, E14

• Registration Number: IRCT138901203667N1
• Lead Sponsor: Vice-chancellor for Research, Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Age 18-70 years, FPG<250mg/dL & HgA1c <9%, not using insulin during past 8 weeks, signing the informed consent
Exclusion criteria: taking selenium supplements during the past 6 months, renal dysfunction (GFR less than 50ml/min), hepatic dysfunction (ALT, AST more than 3xULN), pregnancy, lactation, type 1 diabetes

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified